top of page
News
MitoSense is Accepted into NVIDIA's Inception Program
We are thrilled to announce that MitoSense Inc. has been accepted into the prestigious NVIDIA Inception Program! This milestone marks a...
Jul 29, 2024
MitoSense Chief Medical Officer Submits Statement for the Record to U.S. House VA Committee Hearing
MitoSense's Chief Medical Officer, Dr. Catherine Baucom, has been invited to provide a Statement for the Record for the U.S. House of...
Jun 13, 2024
Hop On A Cure Foundation Announces Investment in MitoSense’s MOT™ Technology to Revolutionize ALS Treatment
SOURCE: Hop On A Cure ATLANTA, Ga. (January 30, 2024) - Nonprofit foundation Hop On A Cure, a leading advocate in the fight against ALS,...
Jan 30, 2024
MitoSense and Uppsala University, in Collaboration with Elliott Mitochondrial Center and Sallie Astor Burdine Breast Foundation, Announce Breakthrough in Mitochondrial Preservation
PLYMOUTH, Mass., Jan. 25, 2024 /PRNewswire/ -- MitoSense Inc., a leading innovator in biotechnology with a focus on neurodegenerative...
Jan 25, 2024
SC Governor Henry McMaster Speaks at Ribbon Cutting for Carroll A. Campbell, Jr. Alzheimer’s Initiative
On January 22, 2024, MitoSense reached an exciting milestone in its fight to treat neurodegenereagtive diseases with the ribbon cutting...
Jan 23, 2024
MitoSense Inc. Completes $3.5 Million Series Seed Funding Round, Led by Caydan Capital Partners
PLYMOUTH, Mass., Jan. 22, 2024 /PRNewswire/ -- MitoSense Inc., a research and development company focused on neurodegenerative disease...
Jan 22, 2024
WATCH: MitoSense Chairman, Van Hipp, Interviewed at NYSE's Space Forum
MitoSense Chairman, Van Hipp, recently sat down for an interview with Trinity Chavez of the New York Stock Exchange during their...
Nov 16, 2023
WRAIR, VA and MitoSense Announce CRADA to Develop Novel Prehospital Treatment for TBI
PLYMOUTH, Mass. and TAMPA, Fla. and SILVER SPRING, Md., Oct. 11, 2023 /PRNewswire/ -- MitoSense, Inc., the James A. Haley Veterans'...
Oct 10, 2023
bottom of page